Home / Market News / $CME
fiscal.ai Corporate Catalyst Impact 65/100 ● neutral

Analysts Adjust Price Targets and Ratings for CME Group

Oct 23, 2026, 2:02 AM UTC · Primary ticker $CME

Multiple financial analysts, including JPMorgan, Piper Sandler, Wells Fargo, and Deutsche Bank, have updated their price targets and ratings for CME Group. JPMorgan notably upgraded the stock to Overweight, indicating a more positive outlook, while others adjusted their price targets upwards, reflecting revised market perspectives and valuations.

On October 22, 2026, CME Group received updated coverage from several prominent financial analysts. JPMorgan upgraded CME's stock from Neutral to Overweight, signaling a more bullish stance, and increased its price target to $367. Concurrently, Piper Sandler, Wells Fargo, and Deutsche Bank also raised their price targets for CME, with Deutsche Bank maintaining a Hold rating. This collective adjustment in price targets and JPMorgan's upgrade reflects a generally more optimistic view among analysts regarding CME Group's market position and future valuation. For traders, this could lead to short-term positive momentum for CME stock, as analyst upgrades often influence investor sentiment and buying activity. The long-term implications depend on whether CME's fundamentals align with these revised, higher valuations, presenting an opportunity for those who believe the company can meet these expectations.

$CME positive Analyst upgrades and increased price targets
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.